A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
Clinical trial NCT07619443 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07619443
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2026-09-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.